EX-23.1 3 lxeo-ex23_1.htm EX-23.1 EX-23.1


Exhibit 23.1

 

img238985936_0.jpg

 

 

KPMG LLP

 

345 Park Avenue

 

New York, NY 10154-0102

Consent of Independent Registered Public Accounting Firm

We consent to the use of our audit report dated March 24, 2025, with respect to the financial statements of Lexeo Therapeutics, Inc., included herein by reference.

/s/ KPMG LLP

New York, New York

March 24, 2025

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

KPMG LLP, a Delaware limited liability partnership and a member firm of

the KPMG global organization of independent member firms affiliated with

KPMG International Limited, a private English company limited by guarantee.

1